Influence of enhanced external counterpulsation on endothelial function: a meta-analysis of randomized controlled trials.

OBJECTIVES

Enhanced external counterpulsation (EECP) is an effective and noninvasive treatment for patients with refractory angina and chronic heart failure. However, previous studies evaluating the influence of EECP on endothelial function showed inconsistent results. This systematic review and meta-analysis was conducted to evaluate the effects of EECP on endothelial function measured by brachial artery flow-mediated dilation (FMD).

DESIGN

PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched for randomized controlled trials comparing the influence of EECP versus usual care on FMD in adult population. A random-effects model incorporating the potential influence of heterogeneity was used to pool the results.

RESULTS

Nineteen studies with 1647 patients were included in the meta-analysis. Compared with usual care or conventional therapy, additional treatment with EECP for 3-7 weeks was associated with a significantly improved FMD (mean difference []: 1.96%, 95% confidence interval [CI]: 1.57-2.36,  < 0.001, = 52%). Subgroup analysis showed consistent results in patients with coronary artery disease and in patients with other diseases ( for subgroup difference = 0.21). Results of meta-regression analysis showed that the mean baseline FMD level was positively correlated with the influence of EECP on FMD (coefficient = 0.42,  < 0.001). Results of subgroup analysis suggested that the increment of FMD following EECP was larger in patients with baseline FMD ≥ 5% (: 2.69, 95% CI: 2.27-3.10,  < 0.001; = 15%) compared to those with baseline FMD < 5% (: 1.49, 95% CI: 1.13-1.85,  < 0.001; = 0%; for subgroup difference < 0.001).

CONCLUSIONS

EECP may be effective in improving endothelial function measured by FMD.